Case Studies

Product Planning, Business acquisition and Strategy

  • Assisted a large US generic company for a period of six years in product selection, business acquisitions and setting up operations in India.

  • Ran the India office for a start up US generic company for 5 years. Pharmaserv was involved in acquiring specialty business like patches and oncology injectable plant in Europe.
        We were also involved in running all India based operations including development, manufacturing and API sourcing.

  • Currently assisting Australia based generic company in establishing business in EU, US and Canada. Pharmaserv is involved in product selection, partner selection and R&D
        coordination for development. Pharmaserv was instrumental in filing their PIV filing. Company recorded sales of US$ 41 Million in 3 years period.

  • Currently Pharmaserv is assisting EU based generic company with focus on niche molecules for EU generic business. Pharmaserv scope includes production section to development of
        molecules to eCTD filing with EU regulated authorities.

    • Taking India to the world

      How we helped put an upcoming Indian pharma company on the world map.

    The Client :

  • One of the leading API manufacturing company based in Mumbai, India.
  • The company has a turnover of around US$ 74 Million (2005-06) with presence in antibiotics (Cephalosporins) and other synthetic products.
  • In 2004, their main area of business, which was India and non-regulated markets, used to account for 100% of the business.
  • The Company has 2 plants located near Ahmedabad and Vapi.

    • The Challenge :

  • The product profile used to consist of old products and no new products were getting launched.
  • None of the international GMP authorities approve the two plants.
  • Introducing new products.
  • Commence business in regulated Markets-USA, EU, Australia etc.
  • Get the plants US FDA approved and EDQM approved.
  • Provide strategic direction and plan for the company.

    • Pharmaserv's Role :

  • Number of new products introduced was totaling 11
  • Vapi plant approved by US FDA.
  • Ahmedabad plant will be approved by March 2007.
  • Supply contracts with leading generic players such as Watson, Teva, Mylan, Apotex, Sandoz, Geopharma, Relonchem, Merck Generics, Hikma & West-Ward etc.
  • Forayed in to a new area of Antibiotics-Carbapenams, which very few companies worldwide have forayed into.
  • Regulated market business accounted for 18% of the total sales in 2006-07, whereas in 2004-05, sales were zero.
  • Forged partnership for supplies to Pfizer, Sanofi-Aventis & GSK.
  • Projected sales mix to be 40% regulated in year 2007-08.
  • Guided the company in filling 5 process patents.
  • Strategic agreement with a US$ 400 Million company for a basket of products (6 generic API's).
  • Put in place profit share agreements for ANDA sales.
    • Maximizing the Indian advantage for you

      What made leading Central American Pharma company regain its institutional market share.

    The Client :

  • It is the second largest company in Central America.
  • It is a major supplier to the institutional markets.
  • Employs over 500 employees.
  • Operations spread over 10 countries.

    • The Challenge :

  • Indian companies were picking up most of the institutional business with their cost advantage.
  • Manufacturing cost of the client was high.
  • There were frequent supply delays.
  • APIs were being procured at high prices due to far distances and inadequate knowledge.

    • Pharmaserv's Role :

  • Reduced the cost of APIs by procuring from manufacturers instead of traders at Indian market prices. We thus became a purchasing arm for the client. Getting them price as per Indian scenario and passing on that benefits to them.
  • Created a contract manufacturing organization for getting key products manufactured at strategic sites across India. The client thus became competitive in the institutional market
  • Initiated new product development at contract sites while we coordinated with the site along with bios.
    • Learning on Indian Technology

      How we assisted a leading pharma company in asia in sourcing cost effective API and new products from the Indian market.

    The Client :

  • Ranking amongst the top 10 pharmaceutical companies in the country.
  • Company employs over 1500 people.
  • Majority brands of the company are amongst the top 3 best selling brands in the country.
  • Youngest company to earn the best exporters award in the country.
  • Company has established prominent presence in various Asian countries.
  • Has cGMP approved manufacturing unit.
  • First company in the country to put up state-of-art sterile facility designed and built to highest standards as lay down by WHO.
  • Company also owns one of the most modern pharmaceutical warehouses, meeting WHO & US FDA guidelines for good warehousing practices.

    • The Challenge :

  • Major challenge company was facing was to keep up the pace of sourcing existing products at competitive price to maintain the profit margins of the company in such a competitive environment.
  • Also to ensure the right quality manufacturer of the raw materials in order to maintain its top most priority of highest quality standards of its brands.
  • Identify new products before any competitor to keep up to the company's pace of launching new products in the market.
  • Development of formulations of these new products at faster pace in order to launch these products much ahead of any competitors.
  • For company's expansion - source equipments and machines from the right manufacturer from India based on its specification and requirements at competitive price.

    • Pharmaserv's Role :

  • PharmaServ's first and foremost objective was to identify the key manufacturers (from India) of existing raw materials, consumed by its client, based on the quality of the product and service offered by these manufacturers.
  • Source & negotiate these raw materials at price which was as competitive as that prevailing in Indian markets, so that the client gets the right quality product at price which are prevailing in India market.
  • Identify new products which various Indian companies are developing or planning for a launch in India itself.
  • Identify new formulation combinations and therapeutic category where the client was not present in the country, but are a big blockbuster in India.
  • Assist client to develop various complex formulations in labs in India and transfer the technology to its client's plant in the country, to speed up the development work & thus the launch of new products for its clients.
  • Identify the manufacturer of various machines and equipments required by its client based on their specific requirements.
  • Forged partnership for supplies to Pfizer, Sanofi-Aventis & GSK.

    • Pharmaserv's Advantage :

      PharmaServ has a unique blend of experience and expertise to deliver the India advantage to all its clients. Our entire approach is to analyze the gaps in your portfolio and help you to bridge them comprehensively.
      We can assist you to be the most competitive in your geographical areas of marketing in the following ways :

      Sourcing of APIs
  • At PharmaServ, we have accumulated comprehensive knowledge of the API industry to put you across to the right manufacturer for a specific product. Traditionally, large Indian players who get products made from smaller manufacturers across the country have dominated the semi regulated API market. Our endeavour is to take you to the most competitive source of a specific product in India as well as to introduce you to smaller quality manufacturers who do not have the means to market their products across the globe and normally depend on traders and larger Indian players.

      • Procurement of machinery & packing material
  • PharmaServ has already assisted several clients to switch from European pharmaceutical machines to quality Indian machines. We have also assisted clients to source packaging material from India resulting in substantial cost savings and operational efficiencies.

      • Product development
  • PharmaServ has access to the entire product development cycle i.e. we have access to infrastructure to develop a product from API and formulation development to commercial scale-up. In short, PharmaServ has the ability to vertically integrate the entire back-end operation through its network of contacts and partnerships.

      • Product Pipeline and Strategy
  • PharmaServ has extensive knowledge of marketed products and patent expiries. We can, therefore, assist clients to build their product pipeline including sourcing or development of products as required.